1 |
A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity
|
|
|
|
BASE
|
|
Show details
|
|
2 |
A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity
|
|
|
|
BASE
|
|
Show details
|
|
3 |
An open-label study of sodium oxybate in spasmodic dysphonia
|
|
|
|
BASE
|
|
Show details
|
|
4 |
Phenotype- and genotype-specific structural alterations in spasmodic dysphonia
|
|
|
|
BASE
|
|
Show details
|
|
5 |
Diagnosis and Treatment of Laryngeal Dystonia: Past, Present and Future Directions
|
|
|
|
BASE
|
|
Show details
|
|
6 |
Neural correlates of abnormal sensory discrimination in laryngeal dystonia
|
|
|
|
BASE
|
|
Show details
|
|
8 |
Invited Article: Recommendations of the Neurolaryngology Study Group on Laryngeal Electromyography
|
|
|
|
BASE
|
|
Show details
|
|
|
|